Ping An Health (01833) rose 4.5 percent in nooncrash1.29%crash1, now reported 10crash1.20 HKDcrash1, the turnover was HK$31.6331 million.
Previously, UBS released a research report, giving Ping An Health a target price of HK$20. The steady progress of Strategy 2.0 has led to a rapid reduction in losses, and the steady growth of F-end business is compounded by the rapid growth of B-end business.
Morgan Stanley said that considering the further reduction of the company's adjusted net loss and the smooth progress of "front-end + back-end" expansion, Ping An Health was awarded a target price of HK$21.